Background: Glutathione transferases (GSTs) are a family of Phase II detoxification enzymes that have been shown to be involved in the development of multi-drug resistance (MDR) mechanism toward chemotherapeutic agents. GST inhibitors have, therefore, emerged as promising chemosensitizers to manage and reverse MDR. Colchicine (COL) is a classical antimitotic, tubulin-binding agent (TBA) which is being explored as anticancer drug.
Methods: In the present work, the interaction of COL and its derivative 2,3-didemethylcolchicine (2,3-DDCOL) with human glutathione transferases (hGSTA1-1, hGSTP1-1, hGSTM1-1) was investigated by inhibition analysis, molecular modelling and molecular dynamics simulations.
Results: The results showed that both compounds bind reversibly to human GSTs and behave as potent inhibitors. hGSTA1-1 was the most sensitive enzyme to inhibition by COL with IC50 22 μΜ. Molecular modelling predicted that COL overlaps with both the hydrophobic (H-site) and glutathione binding site (G-site) and polar interactions appear to be the driving force for its positioning and recognition at the binding site. The interaction of COL with other members of GST family (hGSTA2-2, hGSTM3-3, hGSTM3-2) was also investigated with similar results.
Conclusion: The results of the present study might be useful in future drug design and development efforts towards human GSTs.
[http://dx.doi.org/10.1111/cbdd.13011] [PMID: 28440951]
[http://dx.doi.org/10.1111/cbdd.12574] [PMID: 25891019]
[http://dx.doi.org/10.2174/1389201019666181029103538] [PMID: 30370843]
[http://dx.doi.org/10.2174/1389201020666190119142331] [PMID: 30659535]
[http://dx.doi.org/10.1002/cmdc.201400010] [PMID: 24677708]
[http://dx.doi.org/10.1021/jm00147a014] [PMID: 4032423]
[http://dx.doi.org/10.2174/1871520616666160219161921] [PMID: 26899186]
[http://dx.doi.org/10.1007/s10549-018-4897-5] [PMID: 30054830]